FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20566211000001103: Repaglinide 500microgram tablets (Creo Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69231701000001112 Repaglinide 500microgram tablets (Creo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69231801000001115 Repaglinide 500microgram tablets (Creo Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Is a Product containing precisely repaglinide 500 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has active ingredient Repaglinide false Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has specific active ingredient Repaglinide true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has AMP True Repaglinide 500microgram tablets (Creo Pharma Ltd) Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 90 tablet Has AMP True Repaglinide 500microgram tablets (Creo Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start